🇺🇸 Mepivacaine Injection in United States

16 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

• Window: 22 April 2025 – 22 April 2026
• Total reports: 16

Most-reported reactions

1. Anaesthetic Complication — 3 reports (18.75%)
2. Seizure — 3 reports (18.75%)
3. Toxicity To Various Agents — 3 reports (18.75%)
4. Drug Administered To Patient Of Inappropriate Age — 1 report (6.25%)
5. Incorrect Dose Administered — 1 report (6.25%)
6. Incorrect Route Of Product Administration — 1 report (6.25%)
7. Meningitis Chemical — 1 report (6.25%)
8. Myelopathy — 1 report (6.25%)
9. Pneumocephalus — 1 report (6.25%)
10. Pneumonia Aspiration — 1 report (6.25%)

Source database →

Frequently asked questions

Is Mepivacaine Injection approved in United States?

Mepivacaine Injection does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for Mepivacaine Injection in United States?

Nova Scotia Health Authority is the originator. The local marketing authorisation holder may differ — check the official source linked above.